2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 8, 2007
Grant Date -
Dec 2, 2004
app pub date -
Aug 13, 2002
filing date -
Aug 14, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to piperazine of formula (I) ##STR00001## wherein R represents halogen, C.sub.1-4 alkyl, trifluoromethoxy or trifluoromethyl; R.sub.1 is trifluoromethyl, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, halogen or trifluoromethoxy; R.sub.2 is hydrogen, C.sub.1-4 alkyl or C.sub.2-6 alkenyl; R.sub.3 represents hydrogen or C.sub.1-4 alkyl; n and m are independently 0 or an integer from 1 to 3; and pharmaceutically acceptable salts and solvates thereof, process for their preparation and their use in the treatment of condition mediated by tachykinins and/or by selective inhibition of the serotonin reuptake transporter protein.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully